The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome

Int J Mol Sci. 2022 May 18;23(10):5671. doi: 10.3390/ijms23105671.

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disease that affects exocrine glands, primarily the salivary and lachrymal glands. It is characterized by lymphoplasmacytic infiltration of the glandular tissues, ultimately leading to their dysfunction and destruction. Besides classic dry eyes and dry mouth defined as sicca syndrome, patients affected by the disease also typically display symptoms such as fatigue, pain and in more than 50% of cases, systemic manifestations such as arthritis, interstitial lung involvement, neurological involvement and an increased risk of lymphoma. The pathophysiological mechanisms underlying SS still remain elusive. The crucial role of innate immunity has been advocated in recent years regarding the pathogenesis of pSS, especially in the initiation and progression toward autoimmunity. Alarmins are endogenous molecules that belong to the large family of damage associated molecular pattern (DAMP). Alarmins are rapidly released, ensuing cell injury and interacting with pattern recognition receptors (PRR) such as toll-like receptors (TLR) to recruit and activate cells of the innate immune system and to promote adaptive immunity responses. This review highlights the current knowledge of various alarmins and their role in the pathogenesis of pSS.

Keywords: Sjögren’s syndrome; alarmins; autoimmunity; cytokines; damage associated molecular pattern; innate immunity.

Publication types

  • Review

MeSH terms

  • Alarmins
  • Humans
  • Lacrimal Apparatus* / pathology
  • Sjogren's Syndrome*
  • Toll-Like Receptors
  • Xerostomia*

Substances

  • Alarmins
  • Toll-Like Receptors

Grants and funding

M.S. received a grant from the King Baudouin Foundation for research in Rheumatology.